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Impairment of enzymatic antioxidant defenses is
associated with bilirubin-induced neuronal cell death
in the cerebellum of Ugt1 KO mice
G Bortolussi1,4, E Codarin2,4, G Antoniali2, C Vascotto2, S Vodret1, S Arena3, L Cesaratto2, A Scaloni3, G Tell*,2,5 and AF Muro*,1,5
Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of
unconjugated bilirubin lead to bilirubin-induced encephalopathy and eventually death by kernicterus. Despite extensive studies,
the molecular and cellular mechanisms of bilirubin toxicity are still poorly defined. To fill this gap, we investigated the molecular
processes underlying neuronal injury in a mouse model of severe neonatal jaundice, which develops hyperbilirubinemia as a
consequence of a null mutation in the Ugt1 gene. These mutant mice show cerebellar abnormalities and hypoplasia, neuronal cell
death and die shortly after birth because of bilirubin neurotoxicity. To identify protein changes associated with bilirubin-induced
cell death, we performed proteomic analysis of cerebella from Ugt1 mutant and wild-type mice. Proteomic data pointed-out to
oxidoreductase activities or antioxidant processes as important intracellular mechanisms altered during bilirubin-induced
neurotoxicity. In particular, they revealed that down-representation of DJ-1, superoxide dismutase, peroxiredoxins 2 and 6 was
associated with hyperbilirubinemia in the cerebellum of mutant mice. Interestingly, the reduction in protein levels seems to result
from post-translational mechanisms because we did not detect significant quantitative differences in the corresponding mRNAs.
We also observed an increase in neuro-specific enolase 2 both in the cerebellum and in the serum of mutant mice, supporting its
potential use as a biomarker of bilirubin-induced neurological damage. In conclusion, our data show that different protective
mechanisms fail to contrast oxidative burst in bilirubin-affected brain regions, ultimately leading to neurodegeneration.
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Unconjugated bilirubin (UCB) is themetabolic product of heme
degradation in mammals. The enzymes heme oxygenase 1
and 2 (HO-1, HO-2) catalyze the degradation of heme
into biliverdin, which is subsequently reduced to bilirubin by
biliverdin reductase. In the liver, UCB is conjugated to
glucuronic acid by UDP-glucuronosil transferase (UGT1a1),
rendering it water soluble and excretable in the bile. In
neonates, the late induction of Ugt1a1 gene expression may
result in a limited capacity to conjugate bilirubin. The
imbalance between bilirubin production and its elimination
result in neonatal hyperbilirubinemia. Moderate jaundice is
present in a high proportion of babies and is considered
beneficial because of the antioxidant and cytoprotective
properties of UCB.1 However, excessive hyperbilirubinemia
in newborns may produce acute bilirubin encephalopathy
(BE), bilirubin-induced neurological disorders (BINDs) and
eventually death by kernicterus.2 BIND is characterized by a
wide array of neurological deficits, including irreversible
abnormalities in motor, sensitive and cognitive functions,
because of UCB accumulation in the cerebellum, hippocam-
pus and basal ganglia. Infants affected by null mutations in the
Ugt1 gene develop Crigler–Najjar syndrome type I (CNSI).3
CNSI patients present high UCB plasma levels and are
particularly exposed to BE and BIND if untreated. Current
therapy initially consists in intensive phototherapy (PT) but
liver transplantation is required later in life because of a
reduction in PT efficiency.4,5
Despite extensive investigations in animal models and
in vitro tissue culture cells, the basic mechanisms of
hyperbilirubinemia neurotoxicity have not been fully clarified
yet.6,7 UCB affects a large number of cellular functions
and neurological damage appears to be the result of
their concerted disruption rather than misregulation of a
single pathway. The reported observations range from energy
metabolism,8 cell proliferation,9 DNA and protein synthesis,10
receptor functionality,11 to neurotransmitter uptake and
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release.12 Our group and others reported that UCB is
associated with an increased oxidative stress condition in cell
culture.13,14 In vitro studies showed that exposure to UCB
decreases neuronal and glia viability.15,16 In primary cultures,
it has been observed that UCB permeabilizes mitochondrial
membranes, resulting in mitochondrial swelling, release
of cytochrome c into the cytosol, caspase-3 activation,
Bax translocation and cell death by apoptosis.14,17 Bilirubin
also decreases NGF signaling to AKT and ERKs, interfering
with prosurvival signaling pathways.18 However, most of the
studies leading to potential mechanisms of bilirubin neuro-
toxicity were performed on monotypic cultures with artificial
dosing of bilirubin, lacking the complexity of the interactions
between different cell types, as it occurs in vivo.
The aim of this study was to get a deeper unbiased insight
into the molecular processes underlying bilirubin-induced
neurodegeneration in vivo by using a mouse model
of neonatal hyperbilirubinemia that shows early lethality
because of bilirubin-induced neurological damage.19 Previous
experiments conducted by our lab showed that the cerebellum
of the Ugt1a− /− mouse is the most vulnerable region of the
brain to bilirubin toxicity.19,20 Cerebellar susceptibility to
bilirubin resulted in important alterations of its architecture,
being the external germinal layer (EGL) and the Purkinje
cell layer (PCL) the most affected regions, associated with an
increase of terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick end labeling (TUNEL)-positive
cells.19,20
In this study, we performed a differential proteomic analysis
of the cerebellum from Ugt1 mutant and wild-type (WT) mice
followed by validation of candidate genes both at protein and
RNA levels. Our data point to an impairment of enzymatic
antioxidant processes as important intracellular mechanisms
involved in the onset of bilirubin-induced neurotoxicity in vivo.
Results
The mouse model. To get a deeper insight into the
molecular processes underlying bilirubin-induced neuronal
injury in vivo, we used a mouse strain bearing a targeted
mutation in the Ugt1 gene.19 Mutant mice developed
hyperbilirubinemia within 36 h after birth as evident by the
yellow staining of their skin (Figure 1a, pup on the top). None
of them survived up to 7 days after birth (50% survival was at
P5).20 We monitored total bilirubin (TB) at postnatal day 2
(P2) and P4, showing that bilirubin levels rose rapidly after
birth (Figure 1b) and were significantly different from WT
littermates. As plasma albumin levels were unchanged
between mutant and WT littermates, we calculated bilirubin/
albumin (B/A) ratio. B/A ratio in mutant mice was 111- to 121-
fold increased compared with WT littermates, at P2 and P4,
respectively (Figure 1c). As hyperbilirubinemia proceeded,
mutant mice showed severe neurological deficits and weight
decrease. We daily monitored mutant mice weight since their
birth and we noticed that the first signs of weight reduction
preceded death by about 24 h (Figure 1d).
Nissl staining of brain sections showed that mutant mice
had cerebellar hypoplasia and misshapen of cerebellar
fissures IV, VII and IXb (Figure 1e), confirming prior
results obtained with a less defined genetic background.19
We previously reported an increase in TUNEL-positive cells in
the cerebellum of mutant mice,19,20 indicating that bilirubin
induces neuronal cell death. Western blot analysis of total
cerebellar extracts from mutant mice at P4 showed 2.5-fold
increased levels of cleaved caspase-3 (Figure 1f) compared
with WT littermates.
Differential proteomic analysis of cerebella from Ugt1
mutant and WT mice. As the cerebellum of mutant mice
was severely affected by bilirubin toxicity, we applied a
differential proteomic approach to reveal molecular effectors
involved in bilirubin neurodegeneration and cell death in vivo.
To reduce sample variability, we selected only male mutant
animals showing weight loss at P4 and signs of severe
neurological dysfunctions, such as lethargy and motor
impairment, characterized by a marked improper posture of
the rear limbs, poor and slow movement, and decreased
feeding, as described previously.19 Animals showing these
characteristics were expected to die the next day (P5).
Cerebella from Ugt1 mutant and WT 4-d-old male mice
(n= 4 per genotype) were homogenized and total protein
extracts were obtained. Corresponding SDS-PAGE profiles
were comparable for all the analyzed samples
(Supplementary Figure 1). The majority of protein species
displayed a medium-low molecular weight without any trace
of protein degradation, as evidenced by the presence of
clear, sharp bands. These results confirmed the efficacy of
the protein extraction protocol we used.
To analyze protein expression profile of cerebellar extracts,
the samples for each genotype were pooled and subjected to
two-dimensional electrophoresis (2-DE) analysis. About 200
and 150 reproducible spots were observed and quantified in
the analyses performed in the range of pH 3–10 and 4–7,
respectively (Figure 2a). As expected, the distribution of spots
across the gel was not homogeneous, with a prevalence of
focalized spots in the 20–70 kDa mass range and in the 4–7 pI
range. These proteomic maps were also characterized by the
presence of some horizontal spot trains with different pI
values, which were associated with the same protein entry
(see below), possibly as the results of post-translational
modifications.
Nineteen protein spots (7 and 12 from the analyses in the
range of pH 3–10 and pH 4–7, respectively), displayed a
statistically significant change in abundance (Figure 2 and
Supplementary Figure 2). The distribution of the differentially
represented protein spots across the different replica gels was
homogeneous, thus giving reliability to the analysis we
performed.
Differentially represented proteins, plus those being invar-
iant (used as reference spots), were then excised from the gels
and analyzed by nanoLC-ESI-LIT-MS/MS for protein identifi-
cation (Tables 1 and 2). Data searching in a non-redundant
sequence database allowed the identification of 31 protein
species having molecular masses ranging from 10 to 70 kDa.
For 10 differentially represented spots, identification corre-
sponded to a unique protein species; in the remaining ones
(9 in number), two or more components were identified.
Tables 1 and 2 show the features of each spot, such as gel
coordinates, protein coverage, relative mutant/WT protein
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abundance ratio and known functional properties. All identified
proteins were classified in two groups according to the change
direction in their relative abundance. Table 1 includes the
protein species found to be down-represented in the cerebella
of mutant mice compared with WT counterpart, whereas
Table 2 lists the over-represented protein species.
Identified proteins were then analyzed for their functional
properties in order to evaluate their association with common
biological processes. This analysis was performed using
GeneCodis software, which divides proteins into clusters
according to the molecular function and the biological process
(Figure 2b). The major functional groups contained proteins
involved in oxidation reduction processes or with oxidoreduc-
tase activity (e.g., peroxiredoxin 2, Prdx2; peroxiredoxin 6,
Prdx6; superoxide dismutase, Sod1), as well as proteins
involved in nucleotide-binding or metal ion binding (e.g.,
guanine nucleotide-binding protein G(o) subunit α, Gnao;
enolase 2, Eno2). Worth mentioning was the strong enrich-
ment in enzymatic scavengers (Prdx2, Prdx6, DJ-1 and Sod1)
and development of nervous system (e.g., NADH dehydro-
genase [ubiquinone] flavoprotein 2, Nduv2) (Supplementary
Table 2).
In order to validate 2-DE-based proteomic data and/or to
discriminate between the multiple proteins identified within the
same differentially represented spot, cerebella samples were
also subjected to two-dimensional western blotting analyses
with specific antibodies (Supplementary Figure 3). Validation
was performed on an independent set of biological replicas by
Figure 1 Ugt1 KO mutant mice phenotype and neurological damage. (a) As a consequence of Ugt1a inactivation, the mutant pup (top) appears jaundiced compared with its
WT littermate (bottom). (b) Total plasma bilirubin levels were determined at post natal days 2 and 4 in WT and mutant mice (n≥ 4 time per genotype). Values represent the
mean±S.D. (mg/dl). Two-way ANOVA, ***Po0.001. Interaction time genotype, NS; genotype, ***Po0.001; time, NS. (c) Bilirubin/albumin ratios were determined at P2 and P4
in WT and mutant mice (n≥ 4 time/genotype). Values represent the mean±S.D. of the calculated molar ratio between bilirubin and albumin. Two-way ANOVA, ***Po0.001.
Interaction time genotype, NS; genotype, ***Po0.001; time, NS. (d) Weight curve of WT (black line, n= 7) and mutant mice (red line, n= 7). (e) Nissl staining of 4-day-old (P4)
WT and mutant mice. IV, VII and IXb indicate the cerebellar fissures. Scale bar: 200 μm. (f) Western blot analysis (top panels) of cerebellar protein extracts from P4 WT and
untreated mutant mice, with anti-caspase-3 and anti-cleaved caspase-3 antibodies. Tubulin was used as loading control. Lower panel shows the densitometric quantification of
WB analysis (n= 4 genotype), results are expressed as the mean±S.D. of cleaved caspase-3/tubulin relative ratio
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Figure 2 Changes in expression levels of selected proteins identified by proteomic analysis. (a) Representative proteomic maps of mutant mice cerebella. Mixture of
cerebellar proteins were separated by 2-DE using two immobilized pH gradients, pH 3–10 (left) and pH 4–7 (right), 13-cm in length. Protein patterns were visualized by
ammoniacal silver staining. Vertical and horizontal axes indicate apparent molecular mass and pI values, respectively. Differentially represented protein spots in the mutant mice
are highlighted; numbering in Figure corresponds to numbering in Tables 1 and 2. These spots were subjected to nLC-ESI-LIT-MS/MS analysis for protein identification. (b)
Functional clustering of the identified proteins. Functional enrichment analysis of the protein species identified by proteomic analysis according to molecular function (MF) and
biological process (BP) is shown. GeneCodis analysis of the differentially represented proteins was performed. For simplicity, only the most representative functional categories
are represented. The number of genes for each category is provided on horizontal axis and list only the first 13 co-occurrence terms. Statistical significance belonging to each
category is shown within each bar. See Supplementary Table S2 in Supplementary Material for the full list of annotations. (c–j) Representative gel regions of 2-DE gels stained by
ammoniacal silver were cropped. Protein variation in Ugt1 mutant mice (MUT) with respect to control (WT) are reported in the histograms. Histograms represent the normalized
volume values of each spot of interests as obtained from four independent replicas. Data are the mean±S.D. of four independent experiments. Black boxes represent protein-
normalized expression in the control (WT) mice cerebella, whereas white boxes represent the counterpart in the mutant mice cerebella. For Prdx2 (panel f), the histogram
corresponding to the western blot analysis represents the relative amount of each forms (reduced or oxidized) expressed as percentage of the total amount of protein. Statistical
significance is indicated by an asterisk, Po0.05
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analyzing pooled samples from four additional mice per
genotype. In addition, individual cerebella samples were
also analyzed by one-dimensional western blot analysis
(SDS-PAGE followed by WB), to rule out any bias generated
by the use of pooled samples (Supplementary Figure 4). In all
cases, western blotting results were in agreement with
proteomic data, thus demonstrating a lower representation
of spots of Pcbp1, Prdx2, Prdx6, Pak7/Dj-1 and Sod1 in the
samples from Ugt1 mutant mice, and an increased represen-
tation therein of dihydropyrimidinase-like 3 (Dpysl3), 14-3-3e
and Eno2.
Notably, western blotting of Prdx2 (Figure 2f) revealed that
the protein abundance decrease, as measured by 2-DE in the
mutant mice, was associated with the loss of the protein
reduced form. It also demonstrated a concomitant increase of
the oxidized, more acidic form of the protein, probably resulting
as a consequence of Cys oxidation to sulfinic/sulfonic acid.21
On the other hand, a down-representation of the more
basic protein spot corresponding to the reduced form of
Prdx6 (Figure 2g) was apparent in the 2-DE of the mutant
cerebella, which was confirmed by western blotting analysis
(Supplementary Figure 3).
To highlight whether changes in the abundance of identified
proteins were associated with specific cell types, we
performed immunohistochemical analysis of the selected
proteins. To improve spatial expression pattern discrimination,
we colocalized those proteins with Purkinje cell (PC)-specific
immunostaining (Figure 3). Among the down-represented
proteins, we observed that Pcbp1, DJ-1, Sod1 and Prdx2 were
mainly localized in the EGL and PCs layer, with poor staining in
IGL (Figure 3a). In contrast, Prdx6 staining was more intense
in the PCs layer and localized in the cytoplasmic compartment
of PCs. Generally, the loss in protein content was associated
with reduction in granule neurons (GNs) and PCs of the
EGL and PCs, respectively.
In addition, immunostaining of the over-represented
proteins (Figure 3b) revealed that Dpysl3, Eno2 and 14-3-3e
were mainly localized in the PCL of the WT cerebellum, with
poor staining in the EGL and IGL. On the contrary, we
observed an increased staining of these proteins in the PCL
and EGL of the mutant mice. As in the down-represented
group, all proteins colocalized with PCs marker, although not
all the calbindin-positive PCs expressed those proteins at
equal levels.
Changes in the protein levels are related to post-
translational mechanisms. To determine whether the
observed differences in protein levels were the consequence
of significant changes in the steady state of their mRNAs,
we quantified the corresponding mRNA levels at P4 by
qRT-PCR. No significant differences in mRNA levels were
observed for most of the analyzed genes (Figure 4a and c).
The only exception among the group of under-represented
proteins was Sod1, which showed a statistically significant
decrease in mRNA levels (Figure 4a), as the protein one
(Table 1,Figure 2e and Supplementary Figures 3D and 4). As
NF-E2-related factor 2 (Nrf2) is a master cellular sensor of
oxidative stress,22 we measured its corresponding mRNA
levels by qRT-PCR. As shown in Figure 4b, Nrf2-mRNA levels
were not affected at P2, whereas a significant upregulation
was observed at P4, confirming the induction of an
antioxidant response associated with bilirubin toxicity.
Among the group of over-represented proteins, despite the
observed increase in protein levels (Table 2), Dpysl3 showed
decreased mRNA levels, whereas no significant changes in
Eno2 and 14-3-3e were observed between mutant and
WT cerebellar RNA preparations (Figure 4c). All together,
these results point to post-translational processing as themain
mechanism regulating protein levels in the cerebellum of
Ugt1-/- mutant mice.
Bilirubin-induced cell death is associated with increased
Eno2 in the serum of the mutant mice. As Eno2 in is a
known marker of neurological damage, we investigated in
detail neuronal cell death in the cerebellum of mutant mice,
highlighting the neuronal cell type that was more affected by
bilirubin toxicity. We performed colocalization immunostaining
experiments by using cell-specific markers of PCs (calbindin)
or mature GNs (NeuN), in combination with FluoroJadeC
staining (Figure 5a and b). FluoroJadeC staining detects all
degenerating neurons, regardless of the specific insult(s) or
mechanism(s) of cell death.23 We observed that FluoroJadeC
positivity was strong and colocalized with calbindin-positive
cells in cerebellar sections from mutant mice (Figure 5a).
In contrast, no obvious FluoroJadeC/NeuN colocalization
was observed with NeuN (Figure 5b). Poorly or no positive
cells were detected in cerebellar section from WT littermates
stained with FluoroJadeC. Figure 5c recapitulates FluoroJa-
deC positivity along the cerebellum of mutant mice. We
observed that degenerating neurons were more abundant in
the IV, V and VI fissures (average of 3–10 cells per section);
whereas fissures I, II, VII, VIII and IX were less damaged
(average of 1–3 cells per section). FluoroJadeC-positive
signal in cerebellar fissure X was rarely observed.
Next, we evaluated the quantitative levels of Eno2 in
the serum of the mutant and WT littermates by ELISA test.
Eno2 has been extensively used as a marker of neuronal
injury.24,25 Indeed, we observed an increase of Eno2 serum
levels in mutant mice (Figure 5d). In particular, values were
7.7 and 11.1 μg/l for WT and mutant mice, respectively
(t-test, Po0.05).
P38 pathway is activated in the cerebellum of mutant
mice. Interestingly, six out of the eight selected proteins
(Pcbp1, DJ-1, Sod1, 14-3-3e, Prdx2 and Prdx6) are
connected to the mitogen-activated protein kinase p38
pathway.26–30 Therefore, to verify the involvement of p38 in
bilirubin-mediated stress, we performed immunohistochem-
ical and western blot analysis of cerebella from mutant and
WT mice at P4, using p38 and phospho-p38-specific
antibodies. As shown in Figure 6a, the phospho-p38 signal
was increased in the cerebella of mutant mice. In the PCL,
the signal colocalized with PC, as determined by PC-specific
calbindin-1 staining. Phospho-p38 signal increase was also
observed in the EGL. Western blot analysis showed a
significant increase in phospho-p38 signal in the protein
extracts from mutant mice cerebella (Figure 6b), indicating an
activation of the p38-signaling pathway by bilirubin.
Bilirubin neurotoxicity and oxidative stress
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Discussion
The mechanisms involved in bilirubin neurotoxicity to the
developing nervous system are still poorly understood, and
protein changes related to functional deficits are difficult to be
established. We applied a proteomic approach to a mouse
strain containing a null mutation of the Ugt1 gene with the aim
of shedding light on the mechanisms and molecular effectors
involved in bilirubin-associated neurotoxicity in vivo. Proteo-
mic analysis demonstrated a lower representation of Pcbp1,
DJ-1, reduced forms of Prdx2 and Prdx6, Sod1, Pfdn5, Tctp
and Pebp1 in cerebella from Ugt1 mutant mice, and an
increased representation therein of Dpysl2, Dpysl3, 14-3-3e,
Vat1, Atp6v1a and Eno2.
The mouse model. The mutant mice used in this study are
characterized by severe neonatal hyperbilirubinemia leading
to early death by bilirubin neurotoxicity.19 They display many
of the clinical and histological symptoms of BIND, including
severe motor impairment, poor and slow movement,
decreased feeding, and major changes in cerebellar
architecture. The original strain of mutant mice displays an
Figure 3 Immunohistochemical analysis of the candidate proteins. Representative fluorescent immunohistochemistry of cerebellar sections from WTand mutant mice using
specific antibodies (green/red) and Hoechst (blue) to mark nuclei. (a) Down-represented proteins; (b) over-represented proteins. Calbindin antibody was used to detect PCs.
Scale bar: 50 μm. IGL, internal granular layer; EGL, external germinal layer; PCL, Purkinje cell layer
Bilirubin neurotoxicity and oxidative stress
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important variability on the onset of the disease symptoms
and death, ranging from P4 to P11.19 To reduce sample
variability increasing the powerfulness of the proteomic
approach, we adopted the following strategy: (a) we
increased the homogeneity in the genetic background by
using animals after 49 backcrosses to WT C57Bl/6 mice
(with at least 99.8% of C57Bl/6 genetic background),
which resulted in a sharper mortality curve (death of mice
ranging from P4 to P7, with 50% survival at P5); (b) we daily
monitored the weight of pups because a drop in the weight
curve indicated a critical condition that resulted in animal
death after 24 h; and (c) we analyzed at P4 only those pups
having a weight drop. These aspects resulted in higher
homogeneity of the samples, as evidenced in the 2-DE
replica maps.
Oxidative stress. The proteomic analysis performed in
4-day-old mice cerebellar specimens allowed the identifica-
tion of protein changes associated with early bilirubin-
induced neuronal damage. This comparative analysis
revealed that the most affected biological process was the
cellular response to oxidative stress. Oxidative stress is
considered a major mechanism of bilirubin-induced cytotoxi-
city, as demonstrated by in vitro studies,15,16,31,32 although
confirmation of this hypothesis still needs in vivo experimental
data. In fact, studies performed on Gunn rat pups showed
that lipid peroxidation is not the main mechanism of BIND,33
and there are no reports yet addressing protein oxidation as a
mechanism related to bilirubin cytotoxicity in vivo. However, in
some diseases states in which free radical production have a
main pathogenic role, such as Alzheimer’s disease, biliverdin
reductase undergoes post-translational oxidative modifica-
tions, which may reduce local bilirubin production thus
affecting the overall antioxidant capacity.34 Interestingly,
mildly elevated bilirubin concentrations are considered
antioxidant and, therefore, may assist in neutralizing reactive
oxygen species (ROS) and preventing oxidative damage.35
A redox bilirubin–biliverdin cycling mechanism has
been proposed to explain the antioxidant properties
of bilirubin 36,37 but this hypothesis was not further confirmed
by others.38,39
We also identified Prdx2 and Prdx6, members of the
peroxiredoxin family of enzymes, which serve as scavengers
of cellular peroxides and provide protection against oxidative
stress.40 In the CNS, Prdx2 is almost selectively expressed in
large neurons, such as hippocampal pyramidal and Purkinje
neurons. Hence, oxidation of these proteins could lead to their
increased susceptibility to proteosomal degradation and a
decrease in their protein levels. Indeed, protein oxidation leads
to alterations in protein expression and gene regulation,
protein turnover, modulation of cell signaling and induction of
apoptosis or necrosis.41 Concomitantly, the Nrf2 transcription
factor, a central factor in the adaptive cell response to oxidative
stress,22 was upregulated, confirming a central role of the
oxidative stress in bilirubin toxicity. However, in vivo, Nrf2
increase was not sufficient to activate its target genes involved
in ROS stress response, as evidenced by the absence of
mRNA levels stimulation and the decreased protein amounts,
probably because of the acute and rapid increase in bilirubin
and consequent irreversible cell damage (Figures 4b and 6).
The integral mitochondrial protein DJ-1 is associated with
oxidative stress and scavenges H2O2.
42 It behaves as a
cellular redox sensor and, under oxidative stress conditions or
proteasome block, it exerts its neuroprotective effects pre-
venting aggregate formation.43 Moreover, DJ-1 protects cells
from apoptotic cell death triggered by ROS, and modulates
transcription of antioxidant genes.22 An involvement of DJ-1 in
UCB-induced damage was already reported by our group and
others.13,44 In fact, increased levels of DJ-1 in primary cultures
of hippocampal neurons were reported after 4 h of bilirubin
induction, and in SH-SY5Y cells after 24 h of bilirubin
treatment.44,45 However, in this study we observed a decrease
in DJ-1 levels in the cerebella of mutant mice chronically
affected by hyperbilirubinemia. Our observation is in line with
previous results obtained in primary hippocampal neuron
cultures treated with bilirubin, where DJ-1 levels decreased
24 h post-treatment.44 Thus, the observed increase in cell
death in the cerebella of the hyperbilirubinemic pups may be
related to the decrease in DJ-1 levels, as detected in the
present work.
Another primary cellular defense to oxidative insults is the
scavenger enzyme Sod1. This enzyme catalyzes the rapid
conversion of superoxide anion into molecular oxygen and
hydrogen peroxide. Sod1 mutations are associated with
familiar amyotrophic lateral sclerosis.30 Indeed, Sod1 deletion
Figure 4 Relative expression of mRNA as assessed by qRT-PCR. (a) Candidate
proteins down-represented in 2-DE, were validated at the mRNA level. WT levels
were considered as one. Results are expressed as the mean± S.D. t-test *Po0.05.
(b) Expression levels of NF-E2-related factor 2 (Nrf2) at postnatal days 2 and 4 in WT
and MUT cerebellar extract. Two-way ANOVA, interaction time genotype *Po0.05;
genotype *Po0.05; time **Po0.01. Values represent the mean±S.D. (c) mRNA
expression levels of over-represented candidate proteins. Results are expressed as
the mean± S.D. t-test *Po0.05
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results in increased oxidative stress and axonal degeneration
in vivo.46 Interestingly, we provided the first evidence that
Sod1 is down-represented at the protein level in association
with hyperbilirubinemia in the central nervous system (CNS).
Our observation is in line with the observation that Sod1 is
downregulated at the mRNA level in the myocardium of the
Gunn rat.47
Dpysl3, a member of the TUC (TOAD-64/Ulip/CRMP)
family, known also as CRMP-4 or TUC-4, is involved in
neuronal plasticity and neurite outgrowth and extension.48
Our results are in line with the observed increase in Dpysl3
when SH-SY5Y neuronal cells were treated with UCB.45
However, further experiments are needed to understand
the observed differences between Dpysl3 mRNA and protein
levels.
Pcbp1 is an RNA-binding protein that interacts in a
sequence-specific manner with single-stranded poly(C). It
performs multiple functions including mRNA stabilization,49
translational silencing 50 and translational enhancement.51
Although Pcbp1 is known to affect the stability of gene
expression and axon maturation through post-transcriptional
regulation, its exact functions in neurons are still unclear
and no report so far describes its possible relation with
bilirubin-induced cytotoxicity. However, PCBP1 depletion in
human SH-SY5Y cells affected a number of transcripts
belonging to different categories with pathway involvement in
Wnt (WNT2B, WNT4 and WNT7B) signaling, TGFβ signaling,
translation factors and nuclear receptors.52
We have also noticed that six out of the eight selected
proteins (Pcbp1, DJ-1, Sod1, 14-3-3e, Prdx2 and Prdx6) were
reported to be connected to the mitogen-activated protein
kinase p38 pathway,26–30 which mediates a wide variety of
cellular behaviors ranging from response to stress stimuli and
cell cycle. In particular, p38 activation occurs in response to
inflammatory cytokines, growth factors or other extracellular
stimuli. Importantly, p38 acts both up- and downstream the
apoptotic cascade. The downregulation of these proteins in
the cerebella of mutant mice, as a consequence of increase in
Figure 5 Assessment of bilirubin-induced cell death in the cerebellum at postnatal day 4. (a) Representative fluorescent immunohistochemistry of cerebellar sections from
WT and mutant mice using FluoroJadeC (green) to detect degenerating neurons, colocalized with calbindin antibody (red) to highlight PCs. (b) FluoroJadeC staining was
performed together with NeuN immunostaining (red) to highlight GNs. Hoechst (blue) was used to mark nuclei. Scale bar: 50 μm. IGL, internal granular layer. (c) Cartoon
reporting FluoroJadeC positivity along the entire cerebellum. Values from different sections belonging to the same animal were averaged. Represented values resulted from the
average of four sections per mutant animal (four animals). 0, less than one positive cell/fissure analyzed; +, 1–3 cells; ++, 3–5; +++, 5–10. (d) Serum from WT (n= 5) and MUT
(n= 7) mice was collected at P4 and Eno2 was quantified by ELISA test. Each dot represents a single animal. The mean value for each genotype is indicated (mean± S.D.).
t-test *Po0.05
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Figure 6 Cerebellar bilirubin-induced neurotoxicity in neonatal mice is associated with the activation of P38 pathway. (a) Representative fluorescent immunohistochemistry of
cerebellar sections of WTand mutant mice using P-p38 antibody (green), anti-calbindin-1 antibody (red) to mark PCs and Hoechst (blue) to mark nuclei. Scale bar: 50 μm. IGL,
internal granular layer. (b) Western blot analysis of total cerebellar protein extracts using anti-P-p38 and -p38 antibodies in WT and MUT mice. Tubulin was used as loading
control. Lower panel shows the densitometric quantification of the bands. Error bars S.D. t-test **Po0.01. (c) Model of cerebellar bilirubin-induced neurotoxicity in neonatal mice.
Severe hyperbilirubinemia in vivo leads to cerebellar neurodegeneration and neuronal cell death. Despite increasing transcription levels of Nrf2, a key sensor of oxidative stress
that regulates gene expression of antioxidant genes, proteins involved in the cellular antioxidant defenses are down-represented in the cerebellum of mutant mice. Increase in p38
MAPK phosphorylation leads to apoptosis, as demonstrated by the activation of caspase-3 and the increase in TUNEL-positive cells.19,20 As a consequence of neuronal cell
death, neuronal-specific enolase (NSE) is released into the body fluids and then detected in the serum of Ugt1 mutant mice
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bilirubin, in both systemic and tissue levels,19,53 and ROS,
results in p38 activation, apoptosis and release of neuronal
markers to the body fluids (Figure 6b). The results presented
here confirm previous in vitro studies on cerebellar GNs and
cortical astrocytes, where p38 was activated in response to
bilirubin.54,55 Interestingly, the P-p38-positive signals coloca-
lized with the most affected cerebellar neurons (PCs and GNs
of EGL). However, only PCs showed increased FluoroJadeC
positivity, proving their degeneration and death. In contrast,
GNs reduction was not associated with evident FluoroJadeC
positivity; this, is probably linked to a delay in their replication
cycle in the outer EGL caused by bilirubin rather than cell
death (GB and AFM, unpublished data). Further studies
will demonstrate whether the decrease in antioxidant
defenses is associated with cell cycle regulation in the EGL
of the mutant mice.
The cerebellar postnatal development of mice from birth to
P7/P8 mirrors the window between 24 and 32 gestational
weeks in humans.20,56 This period coincides with the
greatest vulnerability of babies to brain injury,57 leading to
disturbance of myelination58 and neuronal growth. Indeed, the
findings presented here may improve the understanding of the
mechanisms associated to bilirubin neurotoxicity preterm
babies.
Biomarkers of neurological damage. Proteomics analysis
is an important tool to detect reliable biomarkers exploitable
for early detection of pathological states. 14-3-3 Proteins are
a highly conserved group of molecules having pivotal roles in
apoptosis, intracellular trafficking, cell cycle control and
signal transduction, which modulate the interaction between
components of signal transduction pathways.59 They are
abundant in neurons (up to 1% of the total soluble protein in
the brain), and were found in the cerebrospinal fluid of
patients with cerebellar disorders,60 suggesting their possible
use as biomarker of neuronal damage. Specific 14-3-3
isoforms are increased in several brain regions of aged
patients with Alzheimer’s disease and Down syndrome,61
similarly to what observed here in the case of cerebella of
Ugt1 mutant mice.
In this study, we showed that the over-representation of
Eno2 in the cerebellum of mutant mice correlates with a
significant increase in its serum levels. However, the possible
use of this neuro-specific protein as a marker of BIND is
controversial. Increased in Eno2 levels in plasma and
cerebrospinal fluid have previously been observed in Gunn
rats.62 In contrast, piglets infused with bilirubin showed no
differences of Eno2 levels in serum and cerebrospinal fluid,
despite significant changes in auditory brainstem response.63
Studies on jaundiced neonates (serum bilirubin ≥ 20mg/dl)
did not show any correlation between the serum Eno2 and
bilirubin values.64 Conversely, infants having auditory neuro-
pathy presented significantly higher Eno2 levels.64 Our data
on severely affected hyperbilirubinemic mice support Eno2 as
a reliable biomarker of BIND, but its possible use in neonates
still needs further studies.
In conclusion, we show here that severe hyperbilirubinemia
in vivo leads to cerebellar neurodegeneration and neuronal
cell death. By using a 2-DE-based proteomic approach, we
demonstrated that several proteins involved in the cellular
antioxidant defenses are down-represented in the cerebellum
of the Ugt1− /− mouse model. Protein level changes were
mainly the consequence of post-translational mechanisms
because corresponding mRNAs did not show concomitant
variations with respect to control. In addition, we here
provide evidence that neuronal-specific Eno2 (found to be
over-represented in the cerebellum of hyperbilirubinemic
mice) was increased in the plasma of these animals. The
information resulting from this study provides new insights into
the molecular mechanisms associated with bilirubin-induced
neurotoxicity in vivo, suggesting that an improvement
of antioxidant defenses may be of crucial importance to
prevent cerebellar neurodegeneration.
Materials and Methods
Animal model. Ugt1 mutant mice have been described previously.19,20,53 WT
littermates were used as a control. Mice were housed and handled according to
institutional guidelines, and experimental procedures approved by the International
Centre for Genetic Engineering and Biotechnology (ICGEB) board. Animals used in
this study were of 99% C57Bl/6 genetic background, obtained after 49
backcrosses with C57Bl/6 mice. Homozygous mutant animals were obtained by
breeding heterozygous mating pairs. Animals were kept in a temperature-controlled
environment with a 12–12 h light–dark cycle. They received a standard chow diet
and water ad libitum. Four days after birth (P4), mutant mice and their WT
littermates were killed. Brains were removed from the skulls and cerebella were
divided in two hemispheres; one was subjected to protein extraction, whereas the
other was subjected either to RNA extraction and/or brain histology.
Bilirubin determination in plasma. Blood from P4 mice was collected as
previously described.19 Total plasma bilirubin levels were determined with the Direct
and Total Bilirubin Reagent Kit (BQ Kits, Inc., San Diego, CA, USA) as previously
described.20
Albumin determination. Albumin determination in plasma samples was
performed with the Bromocresol Green method, adapting the method to use
minimal volumes (2 μl) as previously described.53 For each test, a standard curve
was performed by diluting of a stock solution (10 mg/ml) of human albumin
(Albuman; 200 g/l, Sanquin, Amsterdam, The Netherlands) in water. Absorbance
values at 630 nm were obtained by using a multiplate reader (Perkin Elmer Envision
Plate Reader, Walthman, MA, USA). Results were expressed as g/l.
Preparation of mouse cerebellar proteins. Total protein extracts were
prepared as already described,65 with minor modifications. Each cerebellum (about
30 mg of tissue) was homogenized using a Potter Dual supplied with a PTFE pestle
and mechanical agitator (ForLab, Bergamo, Italy) in a solution (3 ml) containing 7 M
urea, 2 M thiourea, 4% w/v CHAPS, 0.3% w/v dithiothreitol, IPG buffer (0.5% v/v
ampholytes), Protease Inhibitor Cocktail (Sigma, Milan, Italy) and a trace of
bromophenol blue dye, until490% of the tissue was lysed. Disrupted tissues were
then sonicated and homogenates were centrifuged at 21 000 x g for 30 min to
separate non-solubilized sediment material. A portion of each homogenate was
pooled to obtain a mixture of mutant and WT mice cerebellar proteins, respectively.
These samples were further subjected to proteomics analysis. Four biological
replicas for each genotype were used for proteomic analyses.
Two-dimensional polyacrylamide gel electrophoresis. Fifty or
eighty micrograms of protein extracts were loaded onto 13 cm, pH 3–10 L or pH
4–7 L IPG strips, respectively (Amersham Biosciences, Milan, Italy). Performing
2-DE with two pI ranges allowed a better quantification of protein components not
properly resolved using a single experimental condition. To evaluate technical
reproducibility, gel analyses were performed in technical quadruplicate and
quantified for statistical variation. IEF was conducted using an IPGPhor II system
(Amersham Biosciences) according to the manufacturer’s instructions. Focused
strips were equilibrated as described previously 66 and applied directly to 12% SDS-
polyacrylamide gels and separated at 130 V. Gels were fixed and stained by
ammoniacal silver. For each pool, four experimental replicates were subjected to
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2-DE. All gels images were acquired with an Image Scanner II apparatus
(GE Healthcare, Milan, Italy).
Evaluation of differentially represented spots. Gel images were
analyzed by the Image Master 2D Platinum software (GE Healthcare) that allowed
performing a comparative image analysis, as previously described.66,67 Protein
spots were detected and matched between the different samples; individual spot
volume values were obtained according to the program instruction and normalized
using the program volume normalization function. The ratio for the candidate protein
spots was compared with each other and a mean relative difference in spot intensity
was calculated. Differences in protein spot expression levels were considered as
statistically significant when t-test resulted in a P-valueo0.05.
Mass spectrometry analysis. Identification of the selected spots was
performed as previously described.68 Briefly, spots from 2-DE were manually
excised from gels, minced and washed with water. Proteins were in-gel reduced,
S-alkylated and digested with trypsin. Tryptic digests were desalted and analyzed by
nLC-ESI-LIT-MS/MS using a LTQ XL mass spectrometer (Thermo, San Jose, CA,
USA) equipped with a Proxeon nanospray source connected to an Easy-nanoLC
(Proxeon, Odense, Denmark).69 Peptide mixtures were separated on an Easy C18
column. Spectra acquisition (in the range m/z 400–2000) was controlled by a data-
dependent product ion scanning procedure over the three most abundant ions,
enabling dynamic exclusion (repeat count 2 and exclusion duration 60 s); the mass
isolation window and collision energy were set to m/z 3% and 35%, respectively.
Raw data files from nLC-ESI-LIT-MS/MS experiments were searched with
MASCOT software package version 2.2.06 (Matrix Science, London, UK) against an
updated Mammalia non-redundant sequence database (UniProt 2010/12). Database
searching was performed by selecting Cys carbamidomethylation as a fixed
modification, whereas Met oxidation and pyroglutamate formation at N-terminal Gln
were considered as variable modifications, respectively. It was also carried out by
using a mass tolerance value of 2 Da for precursor ion and 0.8 Da for MS/MS
fragments, trypsin as proteolytic enzyme, and a missed cleavages maximum
value of 2. Candidates with42 assigned peptides with an individual MASCOT score
425, both corresponding to Po0.05 for a significant identification, were considered
as confidently identified. Definitive peptide assignment was always associated with
manual spectral visualization and verification. Protein identification was checked
manually and further evaluated by comparison with their calculated mass and pI
values, using the experimental values obtained from 2-DE.
Gene annotations co-occurrence analysis. Gene IDs corresponding of
differentially represented proteins identified by proteomics analysis were submitted
to GeneCodis (http://genecodis.cnb.csic.es/), a web-based tool for ontological
analysis, selecting Mus musculus as the source for the annotations and two gene
ontology categories (molecular function and biological process) to perform the gene
annotation co-occurrence analysis.
Western blot analysis. To validate proteomic data, protein extracts from an
independent set of biological replica made of pooled samples from four Ugt1 mutant
and four WT mice were loaded onto 7 cm IPG strips, separated by IEF and SDS-
PAGE and then transferred overnight to nitrocellulose support (Schleicher & Schuell,
Keene, NH, USA). Membranes were saturated by incubation with 5% w/v non-fat
dry milk in PBS–0.1% w/v Tween 20 at 4 °C, overnight. Then, blots were incubated
with the primary antibody (listed in Supplementary Table 3) at 4 °C, overnight,
washed and then incubated with the secondary antibody coupled to peroxidase
(Sigma, St. Louis, MO, USA) for 60 min. Blots were developed using the enhanced
chemiluminescence procedure (PIERCE, Rockford, IL, USA). Actin or tubulin were
used as loading controls. Blots were quantified by using a Chemi DOC XRS
densitometer (Bio-Rad, Hercules, CA, USA). To rule out any bias generated by the
use of pooled samples, western blotting was also performed on individual cerebella
resolved by SDS-PAGE.
Preparation of total RNA from the mouse cerebellum and real
time PCR analysis. Total RNA from mouse cerebellum was prepared using
EuroGOLD Trifast (Euroclone, Milano, Italy), according to the manufacturer’s
instructions. One microgram of total RNA was reverse-transcribed using M-MLV
(Invitrogen, Carlsbad, CA, USA) and oligo-dT primers according to the
manufacturer’s instructions. Total cDNA (1 μl) was used to perform qPCR using
the specific primers listed in Supplementary Table 1. qPCR was performed using
the iQ SYBR Green Supermix (Bio-Rad) and a C1000 Thermal Cycler CFX96 Real
Time System (Bio-Rad). Expression of the gene of interest was normalized to the
Gapdh house-keeping gene. Data were analyzed using the ΔΔCt method.
Brain histology and immunofluorescence. Total brains from each
genotype were extracted and fixed with 4% PFA in PBS at 4 °C, overnight. After
cryoprotection in 20% sucrose, 0.02% sodium azide in PBS, specimens were frozen
in cryostat embedding medium (Bio-optica, Milano, Italy) and 14 μm sagittal
sections were obtained in a cryostat. Nissl staining was performed as previously
described.19 For immunofluorescence, 14 μm sagittal sections were blocked in PBS
containing 2.5% BSA and 0.3% Triton X-100, for 2 h, at room temperature (RT).
After blocking, specimens were incubated with the primary antibodies listed in
Supplementary Table 3 in blocking solution, for 2 h, at RT. After three washes with
blocking solution for 5 min, specimens were incubated with the secondary antibody
(Alexa Fluor 488 or 568, Invitrogen) for 2 h, at RT. FluoroJade C (Millipore,
Darmstadt, Germany) was used to visualize all degenerating neurons. Briefly, slides
were treated with 1% NaOH in 80% ethanol for 5 min and then rinsed for 2 min in
70% ethanol, for 2 min in PBS and then incubated in 0.06% potassium
permanganate (Sigma-Aldrich, Milano, Italy) solution for 5 min. After three washes
with PBS, slides were subjected to immunofluorescence procedure as described
above. Following secondary antibody washings, slides were then transferred to a
0.0001% solution of FluoroJade C dissolved in 0.1% acetic acid, for 20 min. The
proper dilution was accomplished by first making a 0.01% stock solution of the dye
in distilled water according to the manufacturer's instructions. Working solution was
prepared immediately before use. Nuclei were visualized by addition of Hoechst
(10 μg/ml, Invitrogen) for 5 min after secondary antibody solution. Nissl-stained
slides were mounted in Eukitt (Fluka, St. Louis, MO, USA), whereas immunostained
slides were mounted in Mowiol 4–88 (Sigma Aldrich, Milano, Italy). Images were
acquired using a Nikon Eclipse E-800 epi-fluorescent microscope bearing a
charged-coupled device camera (DMX 1200F; Nikon, Amstelveen, The Nether-
lands). Digital images were collected using ACT-1 (Nikon) software.
Quantification of serum neuronal-specific Eno2. Neuronal-specific
Eno2 (NSE) was detected in serum samples of mutant and WT littermates at
postnatal day 4 using the CanAg NSE EIA kit (Fujirebio Diagnostic, Inc., Göteborg,
Sweden), according to the manufacturer’s instructions.
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